Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
about
Role of microRNA-7 in digestive system malignancyEvaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingBiological features and biomarkers in hepatocellular carcinomaCurrent systemic treatment of hepatocellular carcinoma: A review of the literatureGenetic alterations in hepatocellular carcinoma: An updateGlypican-3 Targeting Immunotoxins for the Treatment of Liver CancerThe study of a novel sorafenib derivative HLC-080 as an antitumor agentSynergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivoPreclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.The Human Homolog of Drosophila Headcase Acts as a Tumor Suppressor through Its Blocking Effect on the Cell Cycle in Hepatocellular CarcinomaSorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma.DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.Gamma-irradiated β-glucan modulates signaling molecular targets of hepatocellular carcinoma in rats.Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion.
P2860
Q26769922-D2311069-8BD1-497D-9841-B9F7A24D1238Q26783895-6D8766AB-7719-4619-810E-C75CF95182F2Q26799462-B1308317-3DFF-4879-99AC-8F03CE0EC69BQ27026036-0DEACDDF-FFD0-4D15-8610-F42D3F1E0CCDQ28073241-52121AE5-15C4-49F4-9F60-572122679FE4Q28077270-30199D08-805F-416E-A67F-5FEEC616AE06Q28540521-5202F036-A520-4391-91B5-DEB0622CF4F1Q34837850-9B8A0C1E-A37C-4AB4-9DB5-8DC950FF0757Q34995167-A15A0422-D66E-4322-84D2-9AEC0E53E4E8Q35769243-16A97E22-D136-4214-A706-31A5F5697642Q35828564-DB04FAE1-D7DE-48BB-B39E-3F89C8B1F27DQ38803566-6F55F41B-F10E-426D-9EC5-8663049F59F1Q38982079-26A1B48A-1142-4E97-9713-AC6BB78D8EF3Q46659792-EECE9085-539C-4D58-BCEF-61328C7D82BDQ48217983-7FDE6EBC-094B-41D4-99CF-3A0B3B7E88C2
P2860
Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Signaling pathway/molecular ta ...... nt in hepatocellular carcinoma
@en
Signaling pathway/molecular ta ...... nt in hepatocellular carcinoma
@nl
type
label
Signaling pathway/molecular ta ...... nt in hepatocellular carcinoma
@en
Signaling pathway/molecular ta ...... nt in hepatocellular carcinoma
@nl
prefLabel
Signaling pathway/molecular ta ...... nt in hepatocellular carcinoma
@en
Signaling pathway/molecular ta ...... nt in hepatocellular carcinoma
@nl
P2860
P356
P1476
Signaling pathway/molecular ta ...... nt in hepatocellular carcinoma
@en
P2860
P304
P356
10.3748/WJG.V18.I42.6005
P407
P577
2012-11-01T00:00:00Z